Skip to main content
Tech.euFundingExplorerBeta

Topas Therapeutics

A biotechnology company focused on developing products to address areas of major unmet need.

Total raised
€40M
€40,000,000
Funding rounds
2
Investors
8
distinct backers
Active since
2020-10
latest 2021-07

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood15
base rate 48% for Series B
  • Dormant (no round in 3+ cohort gaps)
  • Down/flat last round
  • Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
  • €30M+ raised
  • 20y since founding

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds

Similar companies

same sector or country